Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Care > Global Helicobacter Pylori Screening Test Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Helicobacter Pylori Screening Test Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Medical Care

Published: 2025-08-09

Pages: 133 Pages

Report ld: 4923084

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global Helicobacter Pylori Screening Test market is projected to grow from US$ 480 million in 2024 to US$ 653 million by 2031, at a CAGR of 4.5% (2025-2031), driven by critical product segments and diverse end‑use applications.

A Helicobacter pylori (H. pylori) screening test is a diagnostic procedure used to detect the presence of Helicobacter pylori, a type of bacteria that infects the stomach lining and is associated with gastritis, peptic ulcers, and an increased risk of gastric cancer. Screening tests are typically non-invasive and intended for asymptomatic individuals or those at risk. Common methods include the urea breath test, stool antigen test, and serology (blood antibody test).

Helicobacter Pylori Screening Test Market Size(US$)

M= millions and B=billions

From a downstream perspective, Hospitals accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Helicobacter Pylori Screening Test leading manufacturers including Sekisui Diagnostics, Roche, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories, EKF Diagnostics, Quidel, Cardinal Health, Danaher, Agilent Technologies, etc., dominate supply; the top five capture approximately % of global revenue, with Sekisui Diagnostics leading 2024 sales at US$ million.

Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Helicobacter Pylori Screening Test market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Report Metric
Details
Report Title
Global Helicobacter Pylori Screening Test Market Outlook, In‑Depth Analysis & Forecast to 2031
Forecasted Market Size in 2031
US$ 653 million
CAGR(2025-2031)
4.5%
Market Size Available for Years
2025-2031
Global Helicobacter Pylori Screening Test Companies Covered
Sekisui Diagnostics
Roche
Bio-Rad Laboratories
Thermo Fisher Scientific
Alpha Laboratories
EKF Diagnostics
Quidel
Cardinal Health
Danaher
Agilent Technologies
Coris BioConcept
Global Helicobacter Pylori Screening Test Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Helicobacter Pylori Screening Test Market, Segment by Type
Serology Test
Stool Antigen Test
Urea Breath Test
Global Helicobacter Pylori Screening Test Market, Segment by Application
Hospitals
Physical Examination Centers
Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Defines the Helicobacter Pylori Screening Test study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

Table of Contents

1 Study Coverage
    1.1 Introduction to Helicobacter Pylori Screening Test: Definition, Properties, and Key Attributes
    1.2 Market Segmentation by Type
        1.2.1 Global Helicobacter Pylori Screening Test Market Size by Type, 2020 VS 2024 VS 2031
        1.2.2 Serology Test
        1.2.3 Stool Antigen Test
        1.2.4 Urea Breath Test
    1.3 Market Segmentation by Application
        1.3.1 Global Helicobacter Pylori Screening Test Market Size by Application, 2020 VS 2024 VS 2031
        1.3.2 Hospitals
        1.3.3 Physical Examination Centers
        1.3.4 Others
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Executive Summary
    2.1 Global Helicobacter Pylori Screening Test Revenue Estimates and Forecasts 2020-2031
    2.2 Global Helicobacter Pylori Screening Test Revenue by Region
        2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
        2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
        2.2.3 Global Revenue Market Share by Region (2020-2031)
        2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players
    3.1 Global Helicobacter Pylori Screening Test Player Revenue Rankings and Profitability
        3.1.1 Global Revenue (Value) by Players (2020-2025)
        3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
        3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
        3.1.4 Gross Margin by Top Player (2020 VS 2024)
    3.2 Global Helicobacter Pylori Screening Test Companies Headquarters and Service Footprint
    3.3 Main Product Type Market Size by Players
        3.3.1 Serology Test Market Size by Players
        3.3.2 Stool Antigen Test Market Size by Players
        3.3.3 Urea Breath Test Market Size by Players
    3.4 Global Helicobacter Pylori Screening Test Market Concentration and Dynamics
        3.4.1 Global Market Concentration (CR5 and HHI)
        3.4.2 Entrant/Exit Impact Analysis
        3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis
    4.1 Global Helicobacter Pylori Screening Test Revenue Trends by Type
        4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
        4.1.2 Global Revenue Market Share by Type (2020-2031)
    4.2 Key Product Attributes and Differentiation
    4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
        4.3.1 High-Growth Niches and Adoption Drivers
        4.3.2 Profitability Hotspots and Cost Drivers
        4.3.3 Substitution Threats

5 Global Downstream Application Analysis
    5.1 Global Helicobacter Pylori Screening Test Revenue by Application
        5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
        5.1.2 Revenue Market Share by Application (2020-2031)
        5.1.3 High-Growth Application Identification
        5.1.4 Emerging Application Case Studies
    5.2 Downstream Customer Analysis
        5.2.1 Top Customers by Region
        5.2.2 Top Customers by Application

6 North America
    6.1 North America Market Size (2020-2031)
    6.2 North America Key Players Revenue in 2024
    6.3 North America Helicobacter Pylori Screening Test Market Size by Type (2020-2031)
    6.4 North America Helicobacter Pylori Screening Test Market Size by Application (2020-2031)
    6.5 North America Growth Accelerators and Market Barriers
    6.6 North America Helicobacter Pylori Screening Test Market Size by Country
        6.6.1 North America Revenue Trends by Country
        6.6.2 US
        6.6.3 Canada
        6.6.4 Mexico

7 Europe
    7.1 Europe Market Size (2020-2031)
    7.2 Europe Key Players Revenue in 2024
    7.3 Europe Helicobacter Pylori Screening Test Market Size by Type (2020-2031)
    7.4 Europe Helicobacter Pylori Screening Test Market Size by Application (2020-2031)
    7.5 Europe Growth Accelerators and Market Barriers
    7.6 Europe Helicobacter Pylori Screening Test Market Size by Country
        7.6.1 Europe Revenue Trends by Country
        7.6.2 Germany
        7.6.3 France
        7.6.4 U.K.
        7.6.5 Italy
        7.6.6 Russia

8 Asia-Pacific
    8.1 Asia-Pacific Market Size (2020-2031)
    8.2 Asia-Pacific Key Players Revenue in 2024
    8.3 Asia-Pacific Helicobacter Pylori Screening Test Market Size by Type (2020-2031)
    8.4 Asia-Pacific Helicobacter Pylori Screening Test Market Size by Application (2020-2031)
    8.5 Asia-Pacific Growth Accelerators and Market Barriers
    8.6 Asia-Pacific Helicobacter Pylori Screening Test Market Size by Region
        8.6.1 Asia-Pacific Revenue Trends by Region
    8.7 China
    8.8 Japan
    8.9 South Korea
    8.10 Australia
    8.11 India
    8.12 Southeast Asia
        8.12.1 Indonesia
        8.12.2 Vietnam
        8.12.3 Malaysia
        8.12.4 Philippines
        8.12.5 Singapore

9 Central and South America
    9.1 Central and South America Market Size (2020-2031)
    9.2 Central and South America Key Players Revenue in 2024
    9.3 Central and South America Helicobacter Pylori Screening Test Market Size by Type (2020-2031)
    9.4 Central and South America Helicobacter Pylori Screening Test Market Size by Application (2020-2031)
    9.5 Central and South America Investment Opportunities and Key Challenges
    9.6 Central and South America Helicobacter Pylori Screening Test Market Size by Country
        9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
        9.6.2 Brazil
        9.6.3 Argentina

10 Middle East and Africa
    10.1 Middle East and Africa Market Size (2020-2031)
    10.2 Middle East and Africa Key Players Revenue in 2024
    10.3 Middle East and Africa Helicobacter Pylori Screening Test Market Size by Type (2020-2031)
    10.4 Middle East and Africa Helicobacter Pylori Screening Test Market Size by Application (2020-2031)
    10.5 Middle East and Africa Investment Opportunities and Key Challenges
    10.6 Middle East and Africa Helicobacter Pylori Screening Test Market Size by Country
        10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
        10.6.2 GCC Countries
        10.6.3 Israel
        10.6.4 Egypt
        10.6.5 South Africa

11 Corporate Profile
    11.1 Sekisui Diagnostics
        11.1.1 Sekisui Diagnostics Corporation Information
        11.1.2 Sekisui Diagnostics Business Overview
        11.1.3 Sekisui Diagnostics Helicobacter Pylori Screening Test Product Features and Attributes
        11.1.4 Sekisui Diagnostics Helicobacter Pylori Screening Test Revenue and Gross Margin (2020-2025)
        11.1.5 Sekisui Diagnostics Helicobacter Pylori Screening Test Revenue by Product in 2024
        11.1.6 Sekisui Diagnostics Helicobacter Pylori Screening Test Revenue by Application in 2024
        11.1.7 Sekisui Diagnostics Helicobacter Pylori Screening Test Revenue by Geographic Area in 2024
        11.1.8 Sekisui Diagnostics Helicobacter Pylori Screening Test SWOT Analysis
        11.1.9 Sekisui Diagnostics Recent Developments
    11.2 Roche
        11.2.1 Roche Corporation Information
        11.2.2 Roche Business Overview
        11.2.3 Roche Helicobacter Pylori Screening Test Product Features and Attributes
        11.2.4 Roche Helicobacter Pylori Screening Test Revenue and Gross Margin (2020-2025)
        11.2.5 Roche Helicobacter Pylori Screening Test Revenue by Product in 2024
        11.2.6 Roche Helicobacter Pylori Screening Test Revenue by Application in 2024
        11.2.7 Roche Helicobacter Pylori Screening Test Revenue by Geographic Area in 2024
        11.2.8 Roche Helicobacter Pylori Screening Test SWOT Analysis
        11.2.9 Roche Recent Developments
    11.3 Bio-Rad Laboratories
        11.3.1 Bio-Rad Laboratories Corporation Information
        11.3.2 Bio-Rad Laboratories Business Overview
        11.3.3 Bio-Rad Laboratories Helicobacter Pylori Screening Test Product Features and Attributes
        11.3.4 Bio-Rad Laboratories Helicobacter Pylori Screening Test Revenue and Gross Margin (2020-2025)
        11.3.5 Bio-Rad Laboratories Helicobacter Pylori Screening Test Revenue by Product in 2024
        11.3.6 Bio-Rad Laboratories Helicobacter Pylori Screening Test Revenue by Application in 2024
        11.3.7 Bio-Rad Laboratories Helicobacter Pylori Screening Test Revenue by Geographic Area in 2024
        11.3.8 Bio-Rad Laboratories Helicobacter Pylori Screening Test SWOT Analysis
        11.3.9 Bio-Rad Laboratories Recent Developments
    11.4 Thermo Fisher Scientific
        11.4.1 Thermo Fisher Scientific Corporation Information
        11.4.2 Thermo Fisher Scientific Business Overview
        11.4.3 Thermo Fisher Scientific Helicobacter Pylori Screening Test Product Features and Attributes
        11.4.4 Thermo Fisher Scientific Helicobacter Pylori Screening Test Revenue and Gross Margin (2020-2025)
        11.4.5 Thermo Fisher Scientific Helicobacter Pylori Screening Test Revenue by Product in 2024
        11.4.6 Thermo Fisher Scientific Helicobacter Pylori Screening Test Revenue by Application in 2024
        11.4.7 Thermo Fisher Scientific Helicobacter Pylori Screening Test Revenue by Geographic Area in 2024
        11.4.8 Thermo Fisher Scientific Helicobacter Pylori Screening Test SWOT Analysis
        11.4.9 Thermo Fisher Scientific Recent Developments
    11.5 Alpha Laboratories
        11.5.1 Alpha Laboratories Corporation Information
        11.5.2 Alpha Laboratories Business Overview
        11.5.3 Alpha Laboratories Helicobacter Pylori Screening Test Product Features and Attributes
        11.5.4 Alpha Laboratories Helicobacter Pylori Screening Test Revenue and Gross Margin (2020-2025)
        11.5.5 Alpha Laboratories Helicobacter Pylori Screening Test Revenue by Product in 2024
        11.5.6 Alpha Laboratories Helicobacter Pylori Screening Test Revenue by Application in 2024
        11.5.7 Alpha Laboratories Helicobacter Pylori Screening Test Revenue by Geographic Area in 2024
        11.5.8 Alpha Laboratories Helicobacter Pylori Screening Test SWOT Analysis
        11.5.9 Alpha Laboratories Recent Developments
    11.6 EKF Diagnostics
        11.6.1 EKF Diagnostics Corporation Information
        11.6.2 EKF Diagnostics Business Overview
        11.6.3 EKF Diagnostics Helicobacter Pylori Screening Test Product Features and Attributes
        11.6.4 EKF Diagnostics Helicobacter Pylori Screening Test Revenue and Gross Margin (2020-2025)
        11.6.5 EKF Diagnostics Recent Developments
    11.7 Quidel
        11.7.1 Quidel Corporation Information
        11.7.2 Quidel Business Overview
        11.7.3 Quidel Helicobacter Pylori Screening Test Product Features and Attributes
        11.7.4 Quidel Helicobacter Pylori Screening Test Revenue and Gross Margin (2020-2025)
        11.7.5 Quidel Recent Developments
    11.8 Cardinal Health
        11.8.1 Cardinal Health Corporation Information
        11.8.2 Cardinal Health Business Overview
        11.8.3 Cardinal Health Helicobacter Pylori Screening Test Product Features and Attributes
        11.8.4 Cardinal Health Helicobacter Pylori Screening Test Revenue and Gross Margin (2020-2025)
        11.8.5 Cardinal Health Recent Developments
    11.9 Danaher
        11.9.1 Danaher Corporation Information
        11.9.2 Danaher Business Overview
        11.9.3 Danaher Helicobacter Pylori Screening Test Product Features and Attributes
        11.9.4 Danaher Helicobacter Pylori Screening Test Revenue and Gross Margin (2020-2025)
        11.9.5 Danaher Recent Developments
    11.10 Agilent Technologies
        11.10.1 Agilent Technologies Corporation Information
        11.10.2 Agilent Technologies Business Overview
        11.10.3 Agilent Technologies Helicobacter Pylori Screening Test Product Features and Attributes
        11.10.4 Agilent Technologies Helicobacter Pylori Screening Test Revenue and Gross Margin (2020-2025)
        11.10.5 Company Ten Recent Developments
    11.11 Coris BioConcept
        11.11.1 Coris BioConcept Corporation Information
        11.11.2 Coris BioConcept Business Overview
        11.11.3 Coris BioConcept Helicobacter Pylori Screening Test Product Features and Attributes
        11.11.4 Coris BioConcept Helicobacter Pylori Screening Test Revenue and Gross Margin (2020-2025)
        11.11.5 Coris BioConcept Recent Developments

12 Helicobacter Pylori Screening TestIndustry Chain Analysis
    12.1 Helicobacter Pylori Screening Test Industry Chain
    12.2 Upstream Analysis
        12.2.1 Upstream Key Suppliers
    12.3 Middlestream Analysis
    12.4 Downstream Sales Model and Distribution Networks
        12.4.1 Sales Channels
        12.4.2 Distributors

13 Helicobacter Pylori Screening Test Market Dynamics
    13.1 Industry Trends and Evolution
    13.2 Market Growth Drivers and Emerging Opportunities
    13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Helicobacter Pylori Screening Test Study

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details

Table of Figures

List of Tables
 Table 1. Global Helicobacter Pylori Screening Test Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Helicobacter Pylori Screening Test Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Helicobacter Pylori Screening Test Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Helicobacter Pylori Screening Test Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Helicobacter Pylori Screening Test Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Helicobacter Pylori Screening Test Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Helicobacter Pylori Screening Test Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Helicobacter Pylori Screening Test by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Helicobacter Pylori Screening Test as of 2024)
 Table 11. Global Helicobacter Pylori Screening Test Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Helicobacter Pylori Screening Test Companies Headquarters
 Table 13. Global Helicobacter Pylori Screening Test Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Helicobacter Pylori Screening Test Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Helicobacter Pylori Screening Test Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Helicobacter Pylori Screening Test Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Helicobacter Pylori Screening Test Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Helicobacter Pylori Screening Test High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Helicobacter Pylori Screening Test Growth Accelerators and Market Barriers
 Table 25. North America Helicobacter Pylori Screening Test Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Helicobacter Pylori Screening Test Growth Accelerators and Market Barriers
 Table 27. Europe Helicobacter Pylori Screening Test Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Helicobacter Pylori Screening Test Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Helicobacter Pylori Screening Test Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Helicobacter Pylori Screening Test Investment Opportunities and Key Challenges
 Table 31. Central and South America Helicobacter Pylori Screening Test Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Helicobacter Pylori Screening Test Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Helicobacter Pylori Screening Test Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Sekisui Diagnostics Corporation Information
 Table 35. Sekisui Diagnostics Description and Major Businesses
 Table 36. Sekisui Diagnostics Product Features and Attributes
 Table 37. Sekisui Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Sekisui Diagnostics Revenue Proportion by Product in 2024
 Table 39. Sekisui Diagnostics Revenue Proportion by Application in 2024
 Table 40. Sekisui Diagnostics Revenue Proportion by Geographic Area in 2024
 Table 41. Sekisui Diagnostics Helicobacter Pylori Screening Test SWOT Analysis
 Table 42. Sekisui Diagnostics Recent Developments
 Table 43. Roche Corporation Information
 Table 44. Roche Description and Major Businesses
 Table 45. Roche Product Features and Attributes
 Table 46. Roche Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Roche Revenue Proportion by Product in 2024
 Table 48. Roche Revenue Proportion by Application in 2024
 Table 49. Roche Revenue Proportion by Geographic Area in 2024
 Table 50. Roche Helicobacter Pylori Screening Test SWOT Analysis
 Table 51. Roche Recent Developments
 Table 52. Bio-Rad Laboratories Corporation Information
 Table 53. Bio-Rad Laboratories Description and Major Businesses
 Table 54. Bio-Rad Laboratories Product Features and Attributes
 Table 55. Bio-Rad Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Bio-Rad Laboratories Revenue Proportion by Product in 2024
 Table 57. Bio-Rad Laboratories Revenue Proportion by Application in 2024
 Table 58. Bio-Rad Laboratories Revenue Proportion by Geographic Area in 2024
 Table 59. Bio-Rad Laboratories Helicobacter Pylori Screening Test SWOT Analysis
 Table 60. Bio-Rad Laboratories Recent Developments
 Table 61. Thermo Fisher Scientific Corporation Information
 Table 62. Thermo Fisher Scientific Description and Major Businesses
 Table 63. Thermo Fisher Scientific Product Features and Attributes
 Table 64. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Thermo Fisher Scientific Revenue Proportion by Product in 2024
 Table 66. Thermo Fisher Scientific Revenue Proportion by Application in 2024
 Table 67. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
 Table 68. Thermo Fisher Scientific Helicobacter Pylori Screening Test SWOT Analysis
 Table 69. Thermo Fisher Scientific Recent Developments
 Table 70. Alpha Laboratories Corporation Information
 Table 71. Alpha Laboratories Description and Major Businesses
 Table 72. Alpha Laboratories Product Features and Attributes
 Table 73. Alpha Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Alpha Laboratories Revenue Proportion by Product in 2024
 Table 75. Alpha Laboratories Revenue Proportion by Application in 2024
 Table 76. Alpha Laboratories Revenue Proportion by Geographic Area in 2024
 Table 77. Alpha Laboratories Helicobacter Pylori Screening Test SWOT Analysis
 Table 78. Alpha Laboratories Recent Developments
 Table 79. EKF Diagnostics Corporation Information
 Table 80. EKF Diagnostics Description and Major Businesses
 Table 81. EKF Diagnostics Product Features and Attributes
 Table 82. EKF Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. EKF Diagnostics Recent Developments
 Table 84. Quidel Corporation Information
 Table 85. Quidel Description and Major Businesses
 Table 86. Quidel Product Features and Attributes
 Table 87. Quidel Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Quidel Recent Developments
 Table 89. Cardinal Health Corporation Information
 Table 90. Cardinal Health Description and Major Businesses
 Table 91. Cardinal Health Product Features and Attributes
 Table 92. Cardinal Health Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Cardinal Health Recent Developments
 Table 94. Danaher Corporation Information
 Table 95. Danaher Description and Major Businesses
 Table 96. Danaher Product Features and Attributes
 Table 97. Danaher Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Danaher Recent Developments
 Table 99. Agilent Technologies Corporation Information
 Table 100. Agilent Technologies Description and Major Businesses
 Table 101. Agilent Technologies Product Features and Attributes
 Table 102. Agilent Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Agilent Technologies Recent Developments
 Table 104. Coris BioConcept Corporation Information
 Table 105. Coris BioConcept Description and Major Businesses
 Table 106. Coris BioConcept Product Features and Attributes
 Table 107. Coris BioConcept Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Coris BioConcept Recent Developments
 Table 109. Raw Materials Key Suppliers
 Table 110. Distributors List
 Table 111. Market Trends and Market Evolution
 Table 112. Market Drivers and Opportunities
 Table 113. Market Challenges, Risks, and Restraints
 Table 114. Research Programs/Design for This Report
 Table 115. Key Data Information from Secondary Sources
 Table 116. Key Data Information from Primary Sources


List of Figures
 Figure 1. Helicobacter Pylori Screening Test Product Picture
 Figure 2. Global Helicobacter Pylori Screening Test Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Serology Test Product Picture
 Figure 4. Stool Antigen Test Product Picture
 Figure 5. Urea Breath Test Product Picture
 Figure 6. Global Helicobacter Pylori Screening Test Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospitals
 Figure 8. Physical Examination Centers
 Figure 9. Others
 Figure 10. Helicobacter Pylori Screening Test Report Years Considered
 Figure 11. Global Helicobacter Pylori Screening Test Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Helicobacter Pylori Screening Test Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Helicobacter Pylori Screening Test Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Helicobacter Pylori Screening Test Revenue Market Share by Region (2020-2031)
 Figure 15. Global Helicobacter Pylori Screening Test Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. Serology Test Revenue Market Share by Player in 2024
 Figure 18. Stool Antigen Test Revenue Market Share by Player in 2024
 Figure 19. Urea Breath Test Revenue Market Share by Player in 2024
 Figure 20. Global Helicobacter Pylori Screening Test Revenue Market Share by Type (2020-2031)
 Figure 21. Global Helicobacter Pylori Screening Test Revenue Market Share by Application (2020-2031)
 Figure 22. North America Helicobacter Pylori Screening Test Revenue YoY (2020-2031) & (US$ Million)
 Figure 23. North America Top 5 Players Helicobacter Pylori Screening Test Revenue (US$ Million) in 2024
 Figure 24. North America Helicobacter Pylori Screening Test Revenue (US$ Million) by Type (2020 - 2031)
 Figure 25. North America Helicobacter Pylori Screening Test Revenue (US$ Million) by Application (2020-2031)
 Figure 26. US Helicobacter Pylori Screening Test Revenue (2020-2031) & (US$ Million)
 Figure 27. Canada Helicobacter Pylori Screening Test Revenue (2020-2031) & (US$ Million)
 Figure 28. Mexico Helicobacter Pylori Screening Test Revenue (2020-2031) & (US$ Million)
 Figure 29. Europe Helicobacter Pylori Screening Test Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. Europe Top 5 Players Helicobacter Pylori Screening Test Revenue (US$ Million) in 2024
 Figure 31. Europe Helicobacter Pylori Screening Test Revenue (US$ Million) by Type (2020-2031)
 Figure 32. Europe Helicobacter Pylori Screening Test Revenue (US$ Million) by Application (2020-2031)
 Figure 33. Germany Helicobacter Pylori Screening Test Revenue (2020-2031) & (US$ Million)
 Figure 34. France Helicobacter Pylori Screening Test Revenue (2020-2031) & (US$ Million)
 Figure 35. U.K. Helicobacter Pylori Screening Test Revenue (2020-2031) & (US$ Million)
 Figure 36. Italy Helicobacter Pylori Screening Test Revenue (2020-2031) & (US$ Million)
 Figure 37. Russia Helicobacter Pylori Screening Test Revenue (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Helicobacter Pylori Screening Test Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Top 8 Players Helicobacter Pylori Screening Test Revenue (US$ Million) in 2024
 Figure 40. Asia-Pacific Helicobacter Pylori Screening Test Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Asia-Pacific Helicobacter Pylori Screening Test Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Indonesia Helicobacter Pylori Screening Test Revenue (2020-2031) & (US$ Million)
 Figure 43. Japan Helicobacter Pylori Screening Test Revenue (2020-2031) & (US$ Million)
 Figure 44. South Korea Helicobacter Pylori Screening Test Revenue (2020-2031) & (US$ Million)
 Figure 45. Australia Helicobacter Pylori Screening Test Revenue (2020-2031) & (US$ Million)
 Figure 46. India Helicobacter Pylori Screening Test Revenue (2020-2031) & (US$ Million)
 Figure 47. Indonesia Helicobacter Pylori Screening Test Revenue (2020-2031) & (US$ Million)
 Figure 48. Vietnam Helicobacter Pylori Screening Test Revenue (2020-2031) & (US$ Million)
 Figure 49. Malaysia Helicobacter Pylori Screening Test Revenue (2020-2031) & (US$ Million)
 Figure 50. Philippines Helicobacter Pylori Screening Test Revenue (2020-2031) & (US$ Million)
 Figure 51. Singapore Helicobacter Pylori Screening Test Revenue (2020-2031) & (US$ Million)
 Figure 52. Central and South America Helicobacter Pylori Screening Test Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Central and South America Top 5 Players Helicobacter Pylori Screening Test Revenue (US$ Million) in 2024
 Figure 54. Central and South America Helicobacter Pylori Screening Test Revenue (US$ Million) by Type (2020-2031)
 Figure 55. Central and South America Helicobacter Pylori Screening Test Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Brazil Helicobacter Pylori Screening Test Revenue (2020-2025) & (US$ Million)
 Figure 57. Argentina Helicobacter Pylori Screening Test Revenue (2020-2025) & (US$ Million)
 Figure 58. Middle East and Africa Helicobacter Pylori Screening Test Revenue YoY (2020-2031) & (US$ Million)
 Figure 59. Middle East and Africa Top 5 Players Helicobacter Pylori Screening Test Revenue (US$ Million) in 2024
 Figure 60. South America Helicobacter Pylori Screening Test Revenue (US$ Million) by Type (2020-2031)
 Figure 61. Middle East and Africa Helicobacter Pylori Screening Test Revenue (US$ Million) by Application (2020-2031)
 Figure 62. GCC Countries Helicobacter Pylori Screening Test Revenue (2020-2025) & (US$ Million)
 Figure 63. Israel Helicobacter Pylori Screening Test Revenue (2020-2025) & (US$ Million)
 Figure 64. Egypt Helicobacter Pylori Screening Test Revenue (2020-2025) & (US$ Million)
 Figure 65. South Africa Helicobacter Pylori Screening Test Revenue (2020-2025) & (US$ Million)
 Figure 66. Helicobacter Pylori Screening Test Industry Chain Mapping
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed